These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24916377)

  • 1. Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy.
    Camerino GM; Cannone M; Giustino A; Massari AM; Capogrosso RF; Cozzoli A; De Luca A
    Hum Mol Genet; 2014 Nov; 23(21):5720-32. PubMed ID: 24916377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds.
    Gamberi T; Fiaschi T; Valocchia E; Modesti A; Mantuano P; Rolland JF; Sanarica F; De Luca A; Magherini F
    J Proteomics; 2018 Jan; 170():43-58. PubMed ID: 28966053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
    Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
    Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy.
    Chalkiadaki A; Igarashi M; Nasamu AS; Knezevic J; Guarente L
    PLoS Genet; 2014 Jul; 10(7):e1004490. PubMed ID: 25032964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice.
    Spassov A; Gredes T; Gedrange T; Lucke S; Morgenstern S; Pavlovic D; Kunert-Keil C
    Eur J Orthod; 2011 Dec; 33(6):613-9. PubMed ID: 21187529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle.
    Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ
    Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy.
    Gordon BS; Lowe DA; Kostek MC
    Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
    Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the
    Kiriaev L; Kueh S; Morley JW; Houweling PJ; Chan S; North KN; Head SI
    Am J Physiol Cell Physiol; 2021 Oct; 321(4):C704-C720. PubMed ID: 34432537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of PGC-1α on control of microvascular P(O2) kinetics following onset of muscle contractions.
    Kano Y; Miura S; Eshima H; Ezaki O; Poole DC
    J Appl Physiol (1985); 2014 Jul; 117(2):163-70. PubMed ID: 24833782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
    Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
    Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle ERRγ mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming.
    Matsakas A; Yadav V; Lorca S; Narkar V
    FASEB J; 2013 Oct; 27(10):4004-16. PubMed ID: 23781095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle.
    Ljubicic V; Miura P; Burt M; Boudreault L; Khogali S; Lunde JA; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2011 Sep; 20(17):3478-93. PubMed ID: 21659335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin increases peroxisome proliferator-activated receptor γ Co-activator-1α and utrophin a expression in dystrophic skeletal muscle.
    Ljubicic V; Jasmin BJ
    Muscle Nerve; 2015 Jul; 52(1):139-42. PubMed ID: 25908446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
    De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term quercetin dietary enrichment decreases muscle injury in mdx mice.
    Hollinger K; Shanely RA; Quindry JC; Selsby JT
    Clin Nutr; 2015 Jun; 34(3):515-22. PubMed ID: 24998094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
    Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
    J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis.
    Ljubicic V; Burt M; Lunde JA; Jasmin BJ
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C66-82. PubMed ID: 24760981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.